Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2010
12/08/2010EP2258389A1 Improved bacterial outer membrane vesicles
12/08/2010EP2258388A1 Improved bacterial outer membrane vesicles
12/08/2010EP2258380A1 Substance and composition both capable of imparting heat resistance
12/08/2010EP2258373A1 Composition comprising taurolidine and/or taurultam for the treatment of cancer
12/08/2010EP2258369A1 Medicated patch
12/08/2010EP2258368A2 Pharmaceutical compositions for nasal delivery
12/08/2010EP2258362A2 Titration dosing regimen for controlled release tramadol
12/08/2010EP2258355A1 Patch
12/08/2010EP2258354A1 Compounds and methods for controlling alcohol intake
12/08/2010EP2258353A2 Dosage form containing oxycodone and naloxone
12/08/2010EP2258352A2 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
12/08/2010EP2258351A2 Granules containing lansoprazole in large amount
12/08/2010EP2258350A2 Taste masked dosage form containing roflumilast
12/08/2010EP2258349A2 Swellable dosage form comprising gellan gum
12/08/2010EP2258348A2 Method for preparing microparticles having a selected polymer molecular weight
12/08/2010EP2258347A2 Tamper-resistant products for opioid delivery
12/08/2010EP2258346A2 Solid pharmaceutical dosage form comprising an HIV protease inhibitor solid dispersion
12/08/2010EP2258345A2 Solid pharmaceutical dosage form comprising an HIV protease inhibitor solid dispersion
12/08/2010EP2258344A2 Solid pharmaceutical dosage form comprising a ritonavir and lopinavir solid dispersion
12/08/2010EP2258343A1 Method and kits for delivering drugs by nebulisation
12/08/2010EP2258342A2 Improvements in and relating to carrier particles for use in dry powder inhalers
12/08/2010EP2258341A2 Gastric acid secretion inhibiting composition
12/08/2010EP2257304A1 Sustained release poloxamer containing pharmaceutical compositions
12/08/2010EP2257291A2 Pyridazine derivatives and their use as therapeutic agents in the treatment of skin disorders
12/08/2010EP2257289A1 Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
12/08/2010EP2257288A1 Valsartan solid oral dosage forms and methods of making such formulations
12/08/2010EP2257280A1 Engineered tunable nanoparticles for delivery of therapeutics, diagnostics, and experimental compounds and related compositions for therapeutic use
12/08/2010EP2257279A2 Tablets and preparation thereof
12/08/2010EP2257278A1 Oral tablet compositions containing nateglinide and surfactan ph adjusting agent
12/08/2010EP2257277A1 Solubilisation method
12/08/2010EP2257276A2 Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
12/08/2010EP2257275A2 Ketorolac tromethamine compositions for treating or preventing ocular pain
12/08/2010EP2257274A2 Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle
12/08/2010EP2257273A1 Wettable fillers for improved release of hydrophilic materials from chewing gum compositions
12/08/2010EP2257263A1 Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
12/08/2010EP2257185A1 Methods and compositions of sphingolipid for preventing and treating microbial infections
12/08/2010EP2257173A1 Methods of treating cardiovascular disorders associated with atherosclerosis
12/08/2010EP2257172A2 Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
12/08/2010EP2257159A2 Stable liquid formulations of anti-infective agents and adjusted anti-infective agent dosing regimens
12/08/2010EP2170304B1 A bioerodible patch
12/08/2010EP1904032B1 Fentanyl formulation containing an essential oil
12/08/2010EP1677730B1 Drug-delivery vehicles based on reversed liquid crystalline phase materials
12/08/2010EP1673397B1 Methods for the production and cytotoxicity evaluation of kir2dl nk-receptor antibodies
12/08/2010EP1553924B1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
12/08/2010EP1545472B1 Modified release dosage forms with two cores and an opening
12/08/2010EP1322318B1 Use of probiotic lactic acid bacteria for preventing ultraviolet radiation induced inflammatory or allergic reaction or immunosuppression in the skin
12/08/2010EP1321144B1 Eye drops
12/08/2010EP1116483B1 Oil-in-water emulsion composition
12/08/2010EP1007017B2 Budesonide / formoterol formulation for inhalation having a poured bulk density of 0.30 to 0.36 g/ml, a process for preparing the formulation and the use thereof
12/08/2010EP0772619B2 Immunomodulatory oligonucleotides
12/08/2010CN1993113B Particles comprising a core of calcium phosphate nanoparticles, a biomolecule and a bile acid, methods of manufacturing, therapeutic use thereof
12/08/2010CN1990482B Flavanonol compounds and their production method and use
12/08/2010CN1984644B Stabilised supersaturated solid solutions of steroidal drugs
12/08/2010CN1981739B Esmolol preparation
12/08/2010CN1972670B Pharmaceutical composition
12/08/2010CN1969992B Pharmaceutical composition for treating acne and application method thereof
12/08/2010CN1964699B Dry-form composition for oral ingestion and gel-form composition for oral ingestion of type prepared at time of use
12/08/2010CN1946382B Rapid dissolution formulation of a calcium receptor-active compound
12/08/2010CN1943674B Nettle prodigiosin powders
12/08/2010CN1938034B ED-71 preparation
12/08/2010CN1933856B Cream-gel containing ivermectin
12/08/2010CN1907388B Traditional Chinese medicine for treating bronchitis and bronchial asthma
12/08/2010CN1895438B Chinese-medicinal composition for treating cephalagia and its preparation
12/08/2010CN1893973B Methods for porducing storage stable viruses and immunogenic compositions thereof
12/08/2010CN1864688B Agent for preventing and treating glaucoma
12/08/2010CN1850271B Medicinal composition for treating neurasthenia or somatic form disorders
12/08/2010CN1826170B Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
12/08/2010CN1824061B Application of a combination for preparing medicine and food dual purpose nutrient for preventing true myopia
12/08/2010CN1823745B Patch
12/08/2010CN1814123B Chinese medicine composition for treating diabetes and its preparation method
12/08/2010CN1788753B General glycoside extract from tree peony root bark and its preparation method and uses thereof
12/08/2010CN1774414B New non-ionic surfactants for solubilizing poorly soluble molecules
12/08/2010CN1762357B Oral medicinal formulation of moxifloxacin and its preparation method
12/08/2010CN1742779B Gynostemma pentaphylla oral liquod
12/08/2010CN1698814B Buccal tablet for treating chronic and acute pharyngitis and laryngitis and its preparation method
12/08/2010CN1698611B Nanometer vauqueline liposome and preparation method thereof
12/08/2010CN1594355B Cyclovirobuxinum D crystal, its mono-methanol crystal, and preparation and use thereof
12/08/2010CN1530102B Medical preparation containing alpha-thioctan, ambroxol and/or ACE inhibiting agent and its use in treating neurodegenerative diseases
12/08/2010CN1496741B Method for producing enteric nutrient containing malt ketose
12/08/2010CN1430513B Topical formulations for the transdermal delivery of niacin and method of treating hyperlipidemia
12/08/2010CN1182373B Stabilized gas emulsion containing phospholipid and ultrasound contrast enhancement
12/08/2010CN101910274A Amphiphilic block copolymer micelle composition containing taxane and manufacturing process of the same
12/08/2010CN101909654A Nanoemulsions
12/08/2010CN101909653A Composition exhibiting high osmotic antimicrobial, anti-inflammatory and regeneration activity
12/08/2010CN101909652A Dry powder formulations comprising ascorbic acid derivates
12/08/2010CN101909651A External preparation composition comprising fatty acid-based ionic liquid as active ingredient
12/08/2010CN101909650A Use of an acetylsalicylic acid salt for the treatment of viral infections
12/08/2010CN101909640A Composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of elderly
12/08/2010CN101909614A Nanodispersion
12/08/2010CN101909608A A slow-release formulation based on an association of glycogen and alginate
12/08/2010CN101909607A Transdermal therapeutic system having urea components
12/08/2010CN101909606A Antipruritic sheet
12/08/2010CN101909605A Process for manufacturing chewable dosage forms for drug delivery and products thereof
12/08/2010CN101909604A Method of treating dysglycemia and glucose excursions
12/08/2010CN101909603A An orally-absorbed solid dose formulation for vancomycin
12/08/2010CN101909602A Oral powder and granular antitumor agent
12/08/2010CN101909601A Method to enhance aqueous solubility of poorly soluble actives using methoxypolyethylene glycol
12/08/2010CN101909600A Fast release solid formulation, preparation and use thereof
12/08/2010CN101909599A Counter-pressure filtration of proteins
12/08/2010CN101906147A Conjugate formed by two Arg-Gly-Asp-Ser chains and one fatty alcohol chain through Lys, synthesis thereof and application in medicine
1 ... 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 ... 2991